The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

In 2005, the FDA, without first doing clinical trials, cleared the DePuy ASR Acetabular Cup System for use in traditional hip replacement. Since 2008, the FDA has received numerous complaints regarding the DePuy ASR cup.

According to a report in The New York Times, the ASR, one of several hip models sold by DePuy, belongs to a category of devices known as metal-on-metal implants. Such implants are under increasing scrutiny because they can generate large amounts of metallic debris as they wear. The debris can cause severe inflammatory responses in some patients, damaging muscles and other soft tissues, requiring a follow-up operation to replace the device soon after implant — instead of the 15 or more years artificial hips are supposed to last.

Many of the nation’s leading orthopedic surgeons have reduced or stopped use of these devices because of concerns that they can cause severe tissue and bone damage.

DePuy, in a letter dated March 6, 2010, warned doctors that recently analyzed data suggested that the ASR had a higher-than-expected failure rate when used in traditional hip replacement on certain types of patients (which includes women and patients with weak bones)

Symptoms of a DePuy ASR hip implant failure could include:

* Unexplained Hip Pain
* Thigh Pain or Groin Pain
* Pain with Walking
* Pain Rising from a Seated Position
* Pain with Weight Bearing

If you experienced such symptoms within a few years of hip replacement surgery, make an appointment to see your orthopedist ASAP. If you were the recipient of a DePuy ASR Acetabular Cup System that has failed prematurely, you may be entitled to compensation and other benefits.

If you or someone you know has the ASR XL Acetabular hip replacement system or has experienced any adverse effects, and you would like more information, please contact us at 800-235-0529 or

Comments are closed.

Of Interest